CSX Corporation vs Novo Nordisk A/S — how do they compare? CSX Corporation trades at $50.03 (market cap $92.55B), while Novo Nordisk A/S trades at $45.79 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 2.2× CSX Corporation's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| CSX | NVO | |
|---|---|---|
Market Cap | $92.55B | $207.85B |
Sector | Industrials | Health |
52-Week High | $53.21 | $63.98 |
52-Week Low | $32.05 | $35.29 |
Enterprise Value | $110.52B | $222.55B |
Dividend Yield | 1.12% | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →